News > Cipla Launches Antibody Detection Kit for Covid-19 in India

Cipla Launches Antibody Detection Kit for Covid-19 in India

Drug firm Cipla on Wednesday announced the launch of antibody detection kits for COVID-19 in India under the brand name 'ELIFast' in partnership with KARWA Ltd, under the technology transfer from the Indian Council of Medical Research (ICMR).

ICMR has provided the requisite technical know-how and process for developing the test kits to the approved manufacturers. The product will be marketed under the brand name ELIFast, it added.